You are here

clinical trials

Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23

Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23

Endpoints

clinical trials

Flag link:

Praxis Shares Fall 48% Following Mixed Data for Essential Tremor Candidate

Praxis Shares Fall 48% Following Mixed Data for Essential Tremor Candidate

BioSpace

Praxis Precision Medicines

clinical trials

essential tremor

Flag link:

Incyte Abandons Phase III Trial for Myelofibrosis Treatment

Incyte Abandons Phase III Trial for Myelofibrosis Treatment

BioSpace

clinical trials

Flag link:

Mineralys reports positive data from trial of lorundrostat for hypertension

Mineralys reports positive data from trial of lorundrostat for hypertension

Clinical Trials Arena

Mineralys Therapeutics

clinical trials

Flag link:

Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint

Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint

Clinical Trials Arena

clinical trials

Flag link:

Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure

Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure

BioSpace

renal cell carcinoma

clinical trials

Flag link:

FDA rejects Covid-19 drug over uncertainties around small trial

FDA rejects Covid-19 drug over uncertainties around small trial

Endpoints

clinical trials

Flag link:

Praxis share price halved after essential tremor fail, but biotech still plans phase 3

Praxis share price halved after essential tremor fail, but biotech still plans phase 3

Fierce Biotech

Praxis Precision Medicines

clinical trials

essential tremors

Flag link:

Spotlight – What is next in Nash

Spotlight – What is next in Nash

EP Vantage

clinical trials

Arrowhead Pharmaceuticals

Can-Fite BioPharma

Hepagene Therapeutics

Ligand Pharmaceuticals

Madrigal Pharmaceuticals

NGM Biopharmaceuticals

NorthSea Therapeutics

Sagimet Biosciences

Terns Pharmaceuticals

Viking Therapeutics

Flag link:

Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients

Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients

BioPharma Dive

Bristol Myers Squibb

clinical trials

Flag link:

Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Clinical Trials Arena

Atom Bioscience

clinical trials

Flag link:

Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral

Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral

Fierce Biotech

Atea Pharmaceuticals

clinical trials

Flag link:

Aldeyra reports positive data from dry eye disease therapy trial

Aldeyra reports positive data from dry eye disease therapy trial

Clinical Trials Arena

Aldeyra Therapeutics

clinical trials

dry eye disease

Flag link:

CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing

CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing

Drugs.com

clinical trials

Flag link:

23andMe doses first patient in ph2a anti-tumour monotherapy

23andMe doses first patient in ph2a anti-tumour monotherapy

Pharmaphorum

clinical trials

Flag link:

Merck reports two Phase 3 study misses for Keytruda

Merck reports two Phase 3 study misses for Keytruda

BioPharma Dive

clinical trials

prostate cancer

Flag link:

Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease

Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease

Clinical Trials Arena

Acumen Pharmaceuticals

clinical trials

Alzheimer's disease

monoclonal antibodies

Flag link:

Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market

Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market

Fierce Biotech

Junshi Biosciences

clinical trials

PCSK9 inhibitors

Flag link:

Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner

Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner

Endpoints

Axsome Therapeutics

clinical trials

Alzheimer's disease agitation

Alzheimer's disease

Flag link:

Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access

Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access

Stat

clinical trials

Flag link:

Pages